AstraZeneca Pharma India Limited (ASTRAZEN.BO)
INR 6485.35
(0.07%)
INR 6485.35
(0.07%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 2.6 Billion INR | -35.85% |
| 2022 | 4.28 Billion INR | 13.3% |
| 2021 | 3.78 Billion INR | 4.62% |
| 2020 | 3.61 Billion INR | -8.38% |
| 2019 | 3.94 Billion INR | 3.65% |
| 2018 | 3.8 Billion INR | 21.57% |
| 2017 | 3.13 Billion INR | 0.44% |
| 2016 | 3.11 Billion INR | -11.28% |
| 2015 | 3.51 Billion INR | 21.58% |
| 2014 | 2.89 Billion INR | -8.63% |
| 2013 | 3.16 Billion INR | 6.92% |
| 2012 | 2.96 Billion INR | -5.0% |
| 2011 | 3.11 Billion INR | -0.33% |
| 2010 | 3.12 Billion INR | 83.08% |
| 2009 | 1.7 Billion INR | 46.65% |
| 2008 | 1.16 Billion INR | 3.09% |
| 2007 | 1.12 Billion INR | 14.78% |
| 2006 | 984.17 Million INR | -37.57% |
| 2005 | 1.57 Billion INR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 580.5 Million INR | -6.8% |
| 2023 Q2 | 1.39 Billion INR | 15.17% |
| 2023 Q1 | 1.21 Billion INR | 86.35% |
| 2023 Q4 | 622.82 Million INR | -57.38% |
| 2023 Q3 | 1.46 Billion INR | 4.5% |
| 2023 FY | 2.75 Billion INR | -35.85% |
| 2022 Q3 | 1.25 Billion INR | 12.21% |
| 2022 Q4 | 651.62 Million INR | -48.24% |
| 2022 Q1 | 1.25 Billion INR | 93.48% |
| 2022 Q2 | 1.12 Billion INR | -10.66% |
| 2022 FY | 4.28 Billion INR | 13.3% |
| 2021 Q3 | 1.11 Billion INR | 7.61% |
| 2021 Q4 | 649.08 Million INR | -41.9% |
| 2021 FY | 3.78 Billion INR | 4.62% |
| 2021 Q1 | 980.63 Million INR | 70.11% |
| 2021 Q2 | 1.03 Billion INR | 5.86% |
| 2020 Q2 | 1 Billion INR | 3.87% |
| 2020 FY | 3.61 Billion INR | -8.38% |
| 2020 Q4 | 576.48 Million INR | -45.78% |
| 2020 Q3 | 1.06 Billion INR | 5.5% |
| 2020 Q1 | 970.09 Million INR | 28.85% |
| 2019 Q1 | 1.03 Billion INR | 16.19% |
| 2019 Q2 | 1.05 Billion INR | 1.76% |
| 2019 Q3 | 1.1 Billion INR | 4.88% |
| 2019 Q4 | 752.91 Million INR | -31.9% |
| 2019 FY | 3.94 Billion INR | 3.65% |
| 2018 FY | 3.8 Billion INR | 21.57% |
| 2018 Q3 | 1.14 Billion INR | 15.87% |
| 2018 Q4 | 891.51 Million INR | -21.85% |
| 2018 Q1 | 1.03 Billion INR | 8.79% |
| 2018 Q2 | 984.46 Million INR | -4.7% |
| 2017 Q4 | 949.54 Million INR | -9.28% |
| 2017 Q3 | 1.04 Billion INR | 32.66% |
| 2017 Q2 | 789.03 Million INR | -1.16% |
| 2017 Q1 | 798.26 Million INR | -0.94% |
| 2017 FY | 3.13 Billion INR | 0.44% |
| 2016 Q2 | 948.3 Million INR | 17.01% |
| 2016 Q4 | 805.82 Million INR | -12.59% |
| 2016 Q3 | 921.87 Million INR | -2.79% |
| 2016 FY | 3.11 Billion INR | -11.28% |
| 2016 Q1 | 810.43 Million INR | 17.82% |
| 2015 FY | 3.51 Billion INR | 21.58% |
| 2015 Q4 | 687.87 Million INR | -17.42% |
| 2015 Q3 | 832.98 Million INR | -7.09% |
| 2015 Q2 | 896.58 Million INR | 23.51% |
| 2015 Q1 | 725.94 Million INR | 216.24% |
| 2014 Q4 | 229.55 Million INR | -72.64% |
| 2014 FY | 2.89 Billion INR | -8.63% |
| 2014 Q1 | 912.67 Million INR | 24.9% |
| 2014 Q2 | 910.8 Million INR | -0.2% |
| 2014 Q3 | 838.93 Million INR | -7.89% |
| 2013 Q4 | 730.69 Million INR | -8.87% |
| 2013 FY | 3.16 Billion INR | 6.92% |
| 2013 Q1 | 829.05 Million INR | 16.97% |
| 2013 Q2 | 803.8 Million INR | -3.05% |
| 2013 Q3 | 801.84 Million INR | -0.24% |
| 2012 Q3 | 824.33 Million INR | 5.6% |
| 2012 Q2 | 780.62 Million INR | 4.97% |
| 2012 Q1 | 743.63 Million INR | -20.77% |
| 2012 FY | 2.96 Billion INR | -5.0% |
| 2012 Q4 | 708.75 Million INR | -14.02% |
| 2011 Q4 | 938.56 Million INR | 11.41% |
| 2011 Q3 | 842.44 Million INR | 0.0% |
| 2011 FY | 3.11 Billion INR | -0.33% |
| 2010 FY | 3.12 Billion INR | 83.08% |
| 2009 FY | 1.7 Billion INR | 46.65% |
| 2008 FY | 1.16 Billion INR | 3.09% |
| 2007 FY | 1.12 Billion INR | 14.78% |
| 2006 FY | 984.17 Million INR | -37.57% |
| 2005 FY | 1.57 Billion INR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Ajanta Pharma Limited | 30.46 Billion INR | 91.464% |
| Amrutanjan Health Care Limited | 1.09 Billion INR | -136.618% |
| Sigachi Industries Limited | 579.88 Million INR | -348.432% |
| Bal Pharma Limited | 389.89 Million INR | -566.957% |
| Ind-Swift Laboratories Limited | 2.12 Billion INR | -22.419% |
| Medico Remedies Limited | 161.84 Million INR | -1506.732% |
| Lasa Supergenerics Limited | 291.17 Million INR | -793.074% |
| Venus Remedies Limited | 1.91 Billion INR | -35.7% |
| Sun Pharma Advanced Research Company Limited | 3.07 Billion INR | 15.484% |
| Alpa Laboratories Limited | 156.14 Million INR | -1565.354% |
| Nectar Lifesciences Limited | 625.55 Million INR | -315.698% |
| Shilpa Medicare Limited | 2.18 Billion INR | -19.252% |
| Aarti Drugs Limited | 1.16 Billion INR | -122.736% |
| Lupin Limited | 95.67 Billion INR | 97.282% |
| Aurobindo Pharma Limited | 39.23 Billion INR | 93.372% |
| Zydus Lifesciences Limited | 43.17 Billion INR | 93.977% |
| Windlas Biotech Limited | 1 Billion INR | -158.358% |
| Suven Life Sciences Limited | 109.75 Million INR | -2269.385% |
| Eris Lifesciences Limited | 4.94 Billion INR | 47.392% |
| Valiant Laboratories Limited | 36.28 Million INR | -7065.808% |
| J. B. Chemicals & Pharmaceuticals Limited | 8.41 Billion INR | 69.106% |
| Solara Active Pharma Sciences Limited | 4.57 Billion INR | 43.219% |
| Ipca Laboratories Limited | 13.91 Billion INR | 81.312% |
| Bliss GVS Pharma Limited | 1.41 Billion INR | -83.227% |
| Achyut Healthcare Limited | 1.6 Million INR | -161515.911% |
| Sun Pharmaceutical Industries Limited | 154.18 Billion INR | 98.313% |
| Bajaj HealthCare Limited | 985.34 Million INR | -163.908% |
| RPG Life Sciences Limited | 1.63 Billion INR | -58.997% |
| Mankind Pharma Limited | 23.15 Billion INR | 88.769% |
| Laurus Labs Limited | 3.01 Billion INR | 13.631% |
| Piramal Pharma Limited | 19.91 Billion INR | 86.942% |
| Syncom Formulations (India) Limited | 942.39 Million INR | -175.934% |
| Torrent Pharmaceuticals Limited | 21.42 Billion INR | 87.861% |
| Alembic Pharmaceuticals Limited | 15.86 Billion INR | 83.614% |
| Glenmark Pharmaceuticals Limited | 67.56 Billion INR | 96.151% |
| Unichem Laboratories Limited | 6.72 Billion INR | 61.337% |
| Sequent Scientific Limited | 2.9 Billion INR | 10.387% |
| Novartis India Limited | 470.1 Million INR | -453.159% |
| Wanbury Limited | 1.16 Billion INR | -123.993% |
| Suven Pharmaceuticals Limited | 1.4 Billion INR | -85.374% |
| Wockhardt Limited | 6.4 Billion INR | 59.369% |
| Themis Medicare Limited | 782.85 Million INR | -232.169% |
| Jagsonpal Pharmaceuticals Limited | 773.41 Million INR | -236.225% |
| Jubilant Pharmova Limited | 14.45 Billion INR | 82.009% |
| Glenmark Life Sciences Limited | 11.64 Billion INR | 77.661% |
| Dr. Reddy's Laboratories Limited | 95.87 Billion INR | 97.288% |
| Divi's Laboratories Limited | 14.17 Billion INR | 81.649% |
| NATCO Pharma Limited | 10.05 Billion INR | 74.146% |
| Gufic Biosciences Limited | 1.07 Billion INR | -141.289% |
| IOL Chemicals and Pharmaceuticals Limited | 1.09 Billion INR | -136.658% |
| Ind-Swift Limited | 946.56 Million INR | -174.719% |
| Procter & Gamble Health Limited | 2.99 Billion INR | 13.187% |
| FDC Limited | 5.34 Billion INR | 51.381% |
| Krebs Biochemicals & Industries Limited | 46.15 Million INR | -5533.937% |
| Granules India Limited | 7.18 Billion INR | 63.795% |
| Medicamen Biotech Limited | 335.16 Million INR | -675.852% |
| Alkem Laboratories Limited | 32.83 Billion INR | 92.08% |
| Biofil Chemicals and Pharmaceuticals Limited | 16.2 Million INR | -15942.247% |
| Brooks Laboratories Limited | 51.18 Million INR | -4980.891% |
| Megasoft Limited | 49.52 Million INR | -5150.364% |
| ZIM Laboratories Limited | 1.01 Billion INR | -156.688% |
| Strides Pharma Science Limited | 9.16 Billion INR | 71.618% |
| Neuland Laboratories Limited | 2.92 Billion INR | 11.241% |
| Morepen Laboratories Limited | 1.98 Billion INR | -30.841% |
| Hikal Limited | 2.48 Billion INR | -4.587% |
| Indoco Remedies Limited | 4.74 Billion INR | 45.241% |
| Aarti Pharmalabs Limited | 3.07 Billion INR | 15.418% |
| Kilitch Drugs (India) Limited | 412.42 Million INR | -530.512% |
| Mangalam Drugs & Organics Limited | 676.14 Million INR | -284.591% |
| Hester Biosciences Limited | 908.84 Million INR | -186.123% |